First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Genex
Blog
Self-service tools can bring savings for both payers and providers
The phone in your pocket shouldn’t really be called a phone, should it? After all, making calls isn’t its primary purpose.
Mitchell
News Release
Mitchell Teams With Mazda North American Operations to Launch U.S. Collision Repair Network
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Genex
Virtual Event
Webinar: Onsite Return to Work: A Sikorsky Approach
On-Demand
Since Lockheed Martin (LMC) acquired Sikorsky, medical treatment return-to-work (RTW) protocols have been developed in collaboration with Sik
Genex
Blog
Outdated imaging equipment can affect quality of care and cost of claims
Among specialty services, diagnostic imaging—such as an MRI, CT, or PET scan—is often the first critical step to assess the severity of an injury a
Workers' Comp
News Release
Mitchell Survey Identifies Technologies Most Adopted by Workers' Compensation Organizations During COVID-19 Pandemic
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Genex
Blog
Taking a look at blue light
Approximately one-third of all visible light is “high-energy visible” or “blue” light.